Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Li-Qi Run-Chang Granule for functional constipation
ChiCTR2400083964Phase 2Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangdong Pharmaceutical University
- Start
- May 2024
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Li-Qi Run-Chang granule in functional constipation (FC) (2 arms), sponsored by The First Affiliated Hospital of Guangdong Pharmaceutical University. Primary endpoint: Weekly complete spontaneous bowel movements. Planned start May 2024; status: not yet recruiting.
02
Drugs
Li-Qi Run-Chang granule
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on ChiCTR2400083964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083964.